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There is increasing appreciation for the neurodevelopmental underpinnings of many psychiatric 
disorders. Disorders that begin in childhood such as autism, language disorders or mental 
retardation as well as adult-onset mental disorders may have origins early in neurodevelopment. 
Neural stem cells (NSCs) can be defined as self-renewing, multipotent cells that are present 
in both the embryonic and adult brain. Several recent research findings demonstrate that 
psychiatric illness may begin with abnormal specification, growth, expansion and differentiation 
of embryonic NSCs. For example, candidate susceptibility genes for schizophrenia, autism 
and major depression include the signaling molecule Disrupted In Schizophrenia-1 (DISC-1), 
the homeodomain gene engrailed-2 (EN-2), and several receptor tyrosine kinases, including 
brain-derived growth factor and fibroblast growth factors, all of which have been shown to 
play important roles in NSCs or neuronal precursors. We will discuss here stem cell biology, 
signaling factors that affect these cells, and the potential contribution of these processes to 
the etiology of neuropsychiatric disorders. Hypotheses about how some of these factors relate 
to psychiatric disorders will be reviewed.
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This  review  will  lay  out  some  aspects  of  the  new  frontier 
  represented by stem cells for understanding the origins of men-
tal illness. In section I, we will review embryonic central nervous 
system (CNS) development, focusing on forebrain NSCs and the 
role of the RTKs, such as FGF receptors (FGFRs), in the earliest 
developmental processes. RTKs are transmembrane proteins that, 
upon binding a ligand presented or secreted by nearby cells, phos-
phorylate intracellular signaling molecules and transduce cell-to-
cell signaling in the brain. FGF receptors (FGFRs) are among the 
earliest RTKs expressed in the developing brain, but also continue 
to be expressed in the mature brain.
Following this review of NSCs and FGFs in embryonic devel-
opment, in section II we will describe neurobiological findings in 
clinical populations that support disrupted embryonic stem cell 
activity. In section III, adult NSC functioning and connections with 
mental illness will be reviewed. In section IV, we will discuss how 
new research with inducible pluripotent stem cells derived from 
patients with neuropsychiatric disorders may further our under-
standing of developmental aspect of psychopathology and reveal 
potential targets for psychiatric treatment.
Embryonic cnS DEvElopmEnt
An introDuction to nEurogEnic StEm cEllS (nScs)
Perturbations in early development of the CNS may increase an 
individual’s susceptibility to neuropsychiatric disorders. These per-
turbations may occur at the earliest stages of development, when 
the primordium of the brain is a sheet of neuroepithelial stem 
cells. The functioning of NSCs is tightly regulated by both intrin-
sic and extrinsic factors (Johnson et al., 2009a). Intrinsic factors 
that shape the development of NSCs include transcription factors, 
non-  coding RNAs and covalent modifications of chromatin in the 
introDuction
There  is  a  growing  appreciation  for  the  neurodevelopmental 
  underpinnings of many psychiatric disorders. While the importance 
of the growth and structuring of the brain has long been recognized for 
disorders that begin in childhood such as autism, language disorders 
or mental retardation, there is consensus building that adult-onset 
mental disorders also have origins early in neurodevelopment. In order 
to expand our understanding of these origins, the National Institute of 
Mental Health (NIMH) is investing in studies of developmental neu-
robiology, choosing one of its strategies to be the support of “research 
to improve our basic understanding of the development, structure, 
and function of neural circuits, with a focus on those most relevant to 
mental disorders” (NAMHC, 2008). Forwarding this agenda requires a 
better understanding of the neurobiology of neural stem cells (NSCs) 
and the factors that regulate them in the developing brain.
Neural stem cells can be defined as self-renewing, multipo-
tent cells that are present in both the embryonic and adult brain. 
Several recent research findings demonstrate that psychiatric ill-
ness may begin with abnormal specification, growth, expansion 
and differentiation of embryonic NSCs. For example, candidate 
susceptibility genes for schizophrenia, autism and major depres-
sion include those specifying the signaling molecule Disrupted In 
Schizophrenia-1 (DISC-1), the homeodomain gene engrailed-2 
(EN-2), and several receptor tyrosine kinases (RTKs), including 
brain-derived neurotrophic factor (BDNF) and fibroblast growth 
factors (FGF), all of which have been shown to play important roles 
in NSCs or neuronal precursors. Hypotheses about how some of 
these factors relate to psychiatric disorders are now the focus of 
much neurodevelopmental work (see several reviews: Arnold et al., 
2005; Buckley et al., 2007; Eisch et al., 2008; Thomas and Peterson, 
2008; Jaaro-Peled et al., 2009; Vaccarino et al., 2009).
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cell fate by influencing the specific “mix” of   intrinsic factors 
present at specific locations and times in the developing CNS 
(Figure 1).
One mechanism by which changes in embryonic NSCs could lead 
to behavioral symptoms include an imbalance between production 
of specific types of excitatory and inhibitory neurons, resulting in 
abnormal levels of activation in cortical circuits (Rubenstein and 
Merzenich, 2003). A second mechanism may involve impairments 
in the relative size of cortical areas receiving specific thalamic inputs 
or sending projections to subcortical stations that play an important 
role in emotional/behavioral regulation (Figure 1).
WNT, SHH, and BMP decrease in expression with age, indicat-
ing that their primary function is in establishing early identities of 
NSCs. Continued expression of WNT and SHH in the adult NSC 
niches regulates stem cell proliferation (Lai et al., 2003; Lie et al., 
2005; Palma et al., 2005). In contrast, FGFs continue to be widely 
expressed and play a role not only in adult NSC niches (Zheng et al., 
2004) but also in the maturation of the postnatal cerebral cortex.
FgF ligAnDS, StEm cEll AmpliFicAtion AnD corticAl 
nEurogEnESiS
Fibroblast growth factor ligands are peptides that act both intrac-
ellularly and through secretion into the extracellular space. There 
are 22 known FGFs which act upon the four membrane bound 
nucleus (  epigenetic modifications). All of these factors, a descrip-
tion of which is outside the scope of this review, can influence 
stem cells and their proliferation, or the migration and terminal 
differentiation of their progeny into defined neural cell types with 
specific connectivity (Figure 1).
The specific “mix” of intrinsic factors that characterizes dis-
tinct neural stem cell function and identity acts in conjunction 
with a local “mix” of extracellular signaling molecules bath-
ing NSCs. There are four major classes of secreted extracellular 
signaling molecules that are expressed in the developing brain 
during embryogenesis and that participate in the patterning of 
the nervous system – FGFs, WNTs, Sonic Hedgehog (SHH) and 
Bone Morphogenetic Proteins (BMP). FGFs diffuse from the 
anterior neural ridge, a region corresponding later in develop-
ment to the commissural plate, which is the foremost rostral 
boundary of the telencephalon; WNTs and BMPs emanate from 
the cortical hem, comprising the medial margin of each hemi-
sphere; BMPs are secreted from the roof plate, the dorsal region 
in between the cerebral hemispheres; and SHH diffuses from 
the ventral portion of the neural tube or floor plate (Figure 2). 
In addition to these long-range signals, the balance between 
Notch ligands and Notch receptors, which are membrane bound, 
strongly influences neural stem cell fate (Johnson et al., 2009a). 
Extracellular signals shape CNS   morphogenesis and regulate 
Figure 1 | Two overlapping phases of NSCs – expansion of the stem cell pool and the subsequent switch to the neurogenic period–during embryonic 
development. Changes in stem and progenitor cells (gray cells) and neural precursors (orange cells) during these phases may contribute to later cortical phenotypes 
found in neuropsychiatric disorders. These changes are driven by both extrinsic and intrinsic factors to stem and progenitor cells, which influence each other in 
complex manner.www.frontiersin.org  September 2010  | Volume 4  | Article 59  |  3
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ner upon ligand binding, triggering the activation of three main 
  intracellular pathways, the Ras/MAP Kinase, PI3 kinase, and PLCγ/
Protein Kinase C (Schlessinger, 2000). The cascades eventually 
impinge upon the transcriptional machinery in the cell nucleus. 
Although RAS/MAPK and PI3K pathways are known to be impor-
tant mediators of FGF signaling in the developing CNS, the relative 
role of each of these signaling pathways and of the other putative 
nuclear functions of FGF signaling for transcriptional regulation in 
stem/progenitor cells and biological functions are still unclear.
FGFRs. Amongst the FGF ligands, 13 are known to be expressed 
in  the  CNS  during  embryonic  development  (Fgf1,2,  3,7,8, 
9,10,13,15,16,17,18,22) in specific regions of the neuroepithelium 
(Figure 2). Three of the receptors, FGFR1, FGFR2 and FGFR3 are 
present in the embryonic brain. Indeed, FGFRs are among the earli-
est RTKs expressed in brain development.
Two FGF ligand molecules must bind a receptor dimer in order 
to cause receptor activation. FGF receptors, akin to other mem-
bers of the RTK family of proteins, cross-phosphorylate their part-
Figure 2 | Schematic showing the location of embryonic signaling centers 
at embryonic day (e) 10.5 in the mouse brain. The four families of secreted 
signaling molecules are positioned mainly at and near the midline region. In the 
telencephalon (Frontal view; A) the most prominent source of Fgf activity is 
positioned between the cortical hem (green; a source of WNT and BMP), and 
the ventral SHH source (yellow). As in the forebrain, the same or similar 
signaling molecules direct neural tube patterning and NSC development in the 
remainder of the CNS (B). (C), Dual probe in situ hybridization data exemplifying 
the schematic drawn in (A) in a mouse embryo at the age of E10.5. 
Abbreviations: tel, telencephalon; di, diencephalon; np, nasal processes.Frontiers in Neuroscience  |  Neurogenesis    September 2010  | Volume 4  | Article 59  |  4
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FgFs AnD thE DEvEloping DorSAl tElEncEphAlon
An essential feature of secreted morphogens during development 
is their ability to regulate the neurogenic process in a spatially 
restricted manner. Two distinct areas of the dorsal telencephalon 
are of relevance to the pathophysiology of neuropsychiatric disor-
ders, the cerebral cortex and the hippocampus, the first developing 
primarily prenatally, and the second both prenatally and postna-
tally. In this section we will focus more on the prenatal role of FGF 
receptors on cortical development. Later sections will discuss the 
role of FGF on hippocampal development and relate these phe-
nomena to neuropsychiatric disorders.
FGF8, FGF17 and FGF18 are expressed in the anterior telen-
cephalon (Figure 2), and evidence suggests that this high rostral 
and low caudal gradient of FGF signaling contributes to prefron-
tal cortex (PFC) development (Fukuchi-Shimogori and Grove, 
2001; Cholfin and Rubenstein, 2007). A given amount of FGFs 
in the developing cortical field can determine whether stem cells 
will form specific sub-regions such as somatosensory cortex or 
PFC (Fukuchi-Shimogori and Grove, 2001). Alterations in the 
level of FGFs have been shown to lead to abnormal behaviors 
in animals (Scearce-Levie et al., 2008). FGF8 is negatively regu-
lated by BMP (Crossley et al., 2001; Ohkubo et al., 2002) and in 
turn, FGF8 restricts WNT3a expression, confining it into the hem 
region (Shimogori et al., 2004). WNT3a expression in posterior 
hem regions is important for the formation of the hippocampus 
(Lee et al., 2000).
If we consider the secreted signaling molecules expressed by 
NSCs in the cortical primordium, only disruptions in the FGF path-
ways have thus far resulted in major defects in cortical development 
(Hebert et al., 2003; Cheng et al., 2006). Although overexpression of 
a stabilized β-catenin, which is downstream of the WNT pathway, 
increases cortical size (Chenn and Walsh, 2002), the disruption of 
the WNT pathway affects the hippocampus rather than the cortex 
(Galceran et al., 2000). Thus, normal embryonic cortical develop-
ment primarily depends on FGF signaling, and in order to better 
understand the mechanisms mediating these roles, several FGF 
receptor mutant models have been generated.
Mice that transiently overexpress a dominant negative fgfr1 
gene that interferes with normal functioning of all receptor types 
during early embryogenesis have a smaller cortex, particularly 
in the frontal and temporal regions, and reduced numbers of 
excitatory neurons (Shin et al., 2004). Furthermore, these mice 
exhibited hyperactivity. Specific receptor knockouts have subse-
quently shown the relative contribution of each FGF receptor to 
cortical development. In order to avoid embryonic lethality of 
fgfr1 and fgfr2 systemic gene knockouts, fgfr alleles containing 
loxP site have been recombined in vivo with a variety of Cre lines, 
including the foxg1 knock-in Cre, nestin-Cre and hgfap-Cre lines. 
Mice lacking fgfr1 in radial glial progenitors driven by hgfap-
Cre (which targets the dorsal telencephalon and hippocampal 
anlage),  exhibited  severe  reduction  of  hippocampal  volume, 
almost complete absence of midline telencephalic commissures 
due to abnormal development of midline glia, and decreased 
inhibitory interneuron number in the cortex and hippocampus 
(Ohkubo et al., 2004; Smith et al., 2006; Muller Smith et al., 
2008). In contrast, the number of cortical excitatory neurons was 
not decreased in mice lacking fgfr1 alone (Muller Smith et al., 
Concurrently with patterning in the developing dorsal telen-
cephalon, NSCs expand in number. Through a developmental 
switch not yet fully understood, after the majority of this expan-
sion has occurred, stem cells then begin to generate neuronal pre-
cursors in a neurogenic phase that lasts for approximately 6 days 
in rodents and 10–12 weeks in primates (Caviness et al., 1995; 
Rakic, 1995) (Figure 1). Cortical excitatory neurons are derived 
from NSC that line the dorsal telencephalic ventricle. The primary 
stem cells in this ventricular zone (VZ) are called radial glia because 
of their expression of glial markers such as GFAP and GLAST, and 
their cellular morphology. Radial glial cells have an apical end foot 
attachment at the ventricle, a cell body that is near the ventricle, 
and a long radial process that is attached at the pial surface (Levitt 
et al., 1981). Radial glia can undergo self-renewing cell divisions, or 
asymmetric cell divisions that directly give rise to neurons (Noctor 
et al., 2001). Another product of radial glial division are committed 
neurogenic progenitors that migrate to the subventricular zone 
(SVZ), above the VZ, where they in turn proliferate to give rise to 
neurons. The committed neuronal progenitors of the SVZ, referred 
to as intermediate progenitor cells (IPCs) express the transcription 
factor TBR2 and lack the self-renewal properties of true stem cells 
(Pontious et al., 2008). However, their proliferation is important 
for the expansion of cortical layers, as demonstrated by the decrease 
in cortical surface area and thickness in mice lacking tbr2 (Arnold 
et al., 2008; Sessa et al., 2008).
Fibroblast growth factor signaling is important for the regula-
tion of neurogenesis in the developing cortex. Studies in vitro 
originally suggested that the ability of a cortical NSC to stop self-
renewing and begin the differentiation process was somehow 
delayed by increased FGF signaling, resulting in an expanded 
stem cell pool (Kilpatrick and Bartlett, 1993). The first in vivo 
demonstration was provided by injection of an FGF ligand, FGF2, 
in rat embryonic brain ventricles, which resulted in an expanded 
cortex with increased excitatory neuron production (Vaccarino 
et al., 1999). Conversely, the deletion of the fgf2 gene resulted in 
a cortex with reduced numbers of glutamatergic excitatory neu-
rons, particularly in the anterior neocortex (Raballo et al., 2000; 
Korada et al., 2002). This was not due to a change in the cell cycle 
or by alterations in cell survival, suggesting that FGF signaling 
might affect the early amplification of stem cells or their immedi-
ate descendants (Raballo et al., 2000). This was confirmed by later 
work performed on FGF receptor knockout mice (see FGFs and 
the Developing Dorsal Telencephalon).
Similarly, mice with reduced fgf8 gene expression have decreased 
proliferation and increased numbers of apoptotic cells in the devel-
oping telencephalon (Fukuchi-Shimogori and Grove, 2001; Garel 
et al., 2003; Storm et al., 2006). However, reducing the gene dosages 
of fgf15 has opposite effects (Borello et al., 2008) with fgf15 expres-
sion in the telencephalon promoting cell differentiation, inhibit-
ing proliferation, and promoting the expression of the coup-tf1 
transcription factor, which plays a role in the development of layer 
four neurons and posterior cortex (Gimeno et al., 2003; Borello 
et al., 2008). Therefore, the combination of different FGFs and 
other cell extrinsic signaling proteins expressed in the neurogenic 
period may regulate the behavior of stem cells and the production 
of neuroblasts in a precise sequence, resulting in the establishment 
of a cortex with the correct number of neurons.www.frontiersin.org  September 2010  | Volume 4  | Article 59  |  5
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corticAl intErnEuron DEvElopmEnt
The ganglionic eminences of the ventral telencephalon give rise to 
the striatum which emerges from the lateral ganglionic eminence 
(LGE), and to cortical and hippocampal GABA interneurons which 
are born in the medial and caudal ganglionic eminences (MGE and 
CGE). Parvalbumin (PV)+ and somatostatin (Sst)+ interneurons 
arise from the MGE, while calretinin+ interneurons arise largely 
from the CGE (Wonders et al., 2008). The interneurons from the 
MGE and CGE travel to the cortex via tangential migration dur-
ing embryogenesis and progressively integrate into the cortical 
circuitry. Postnatally they undergo a protracted maturation and 
develop into their mature interneuron subtypes through processes 
that are largely unknown.
FGFR1 and FGFR2 appear to regulate early patterning of the 
ganglionic eminences before neurogenesis (Gutin et al., 2006). We 
shown that loss of fgfr1 or fgfr2 in the cerebral cortex via hgfap-Cre 
mediated recombination, which does not target the ganglionic emi-
nences, results in a decrease in PV+ and Sst+ interneurons within 
the cortex (Smith et al., 2008). Work in our lab suggests that this 
deficit develops postnatally, and does not arise from defects in the 
patterning or proliferation of stem cells and progenitors in the 
ventral telencephalon. FGFR1 may act in the developing postna-
tal neocortex to support the survival and maturation of GABA 
interneurons.
clinicAl StuDiES
Biological mechanisms of neuropsychiatric disorders can be studied 
in clinical populations using multiple lines of inquiry. Structural 
brain imaging can reveal changes in brain region volume while 
functional imaging can demonstrate altered functioning of brain 
regions, both of which may originate in early developmental proc-
esses, particularly when found in patients presenting early in the 
course of illness or young subjects at high risk for psychiatric dis-
orders. More specific mechanisms relevant to stem cell biology may 
be examined in the post mortem brain as well as genetic analysis 
of patients. Converging evidence from populations of patients 
with autism, schizophrenia and affective disorders suggests that 
stem cell biology is implicated in neuropsychiatric etiology and 
pathophysiology.
AutiSm
The brain structure of patients with autism spectrum disorders 
(ASD) including autism, Asperger’s Disorder (AD) and pervasive 
development disorder not otherwise specified (PDD-NOS) has 
been found to be abnormal using several different approaches. It 
is now widely believed that at least some of the deficits are present 
very early in life and that abnormal embryonic brain development 
may be a contributor to later structural deficits.
The head circumference of some patients with autism has long 
been known to be larger (Davidovitch et al., 1996; Woodhouse 
et al., 1996; Fombonne et al., 1999; Miles et al., 2000) because of 
abnormal acceleration in growth in early infancy (Courchesne et al., 
2003). While no studies have been published on the neuroanatomy 
of high-risk individuals before a diagnosis of autism is made, ret-
rospective data have shown that children with macrocephaly and 
autism do not have increased head circumference at birth (Lainhart 
et al., 1997; Courchesne et al., 2003; Dementieva et al., 2005; Redcay 
2008). However, mice lacking fgfr2 alone or in combination with 
fgfr1, via hgfap-Cre mediated recombination, showed a decrease 
in cortical excitatory neurons and volume, both of which were 
more pronounced in the medial prefrontal area of the cortex 
(Stevens et al., 2010). The mechanism of these abnormalities 
leading to a loss of cortical excitatory neurons resides in the 
ability of FGFR2 signaling to induce radial glial stem cells to re-
enter the cell cycle, particularly in anterior regions. Therefore, 
FGFR2 support prefrontal cortical development by promoting 
the self-renewal or maintenance of cortical stem cells. These data 
converge with previous work demonstrating that PFC size is 
reduced by knockout of FGF17, a ligand for FGFR2 (Cholfin 
and Rubenstein, 2008).
Consistent with the decreased number of excitatory projection 
neurons in PFC in conditional knockouts for fgfr2 driven by the 
hgfap-Cre transgene, glutamatergic synapses in the bed nuclei of 
the stria terminalis (BST), an area that receives projections from the 
PFC and in turn projects to the hypothalamus, were also reduced 
in these mice. A decreased number of GABAergic neurons in the 
BST was also noted in these animals, which is likely to be secondary 
to decreased glutamate input, as FGFR2 was not targeted in this 
region (Stevens et al., 2010). These changes may have important 
consequences for the correct functioning of limbic circuitry.
Mice constitutively lacking FGFR3 through the germline have 
skeletal defects but have not been reported to have abnormal cor-
tical morphogenesis. (Colvin et al., 1996; Oh et al., 2003). On the 
other hand, mice with activating mutations of fgfr3 have an increase 
in the rate of the cell cycle of cortical stem cells in early neurogenesis 
and an increase in the generation of TBR2+ IPCs at later stages, 
leading to increased cortical size and cortical cell number (Inglis-
Broadgate et al., 2005; Thomson et al., 2007, 2009). The caudal 
and lateral areas of the cortex were most affected, reflecting the 
natural gradient of fgfr3 expression. Thus, FGFR2 and FGFR3 both 
appear to influence the appropriate proliferation of stem cells in 
different regions of cortex (anterior and posterior, respectively), 
suggesting that the regulation of signaling by each of these receptors 
individually and in combination may be critical for the appropri-
ate expansion of different cortical areas. Compound mutation for 
fgfr1, fgfr2 and fgfr3 in the early anterior neural tube (driven by 
foxg1-Cre) results in an almost complete agenesis of both dorsal 
and ventral telencephalic regions (Gutin et al., 2006; Hebert and 
Fishell, 2008).
The downstream targets that mediate FGF regulated cellular 
events are still under investigation. Relevant to the early pattern-
ing processes in the cortex, FGF8-mediated activation of FGFRs is 
known to repress genes that specify dorsal and posterior cell fate 
including coup-tf1, emx2, and wnt8b (Crossley et al., 2001; Garel 
et al., 2003; Storm et al., 2006). FGF and other signaling factors also 
induce RAS/MAPK pathways, supporting NSC proliferation and 
self-renewal, and PI3K/AKT pathways, supporting cell survival. 
Several transcription factor genes are also activated by FGF signal-
ing in NSCs as well as neuronal progeny, including pea3, erm (etv5), 
and er81 (etv1) some of which are anteriorly expressed (Hasegawa 
et al., 2004; Cholfin and Rubenstein, 2008) and may be involved in 
cell differentiation or fate. The multiplicity of targets demonstrates 
how master regulatory factors such as FGF may exert multifaceted 
roles in stem cells and their progenies.Frontiers in Neuroscience  |  Neurogenesis    September 2010  | Volume 4  | Article 59  |  6
Stevens et al.  Stem cells and neuropsychiatric disorders
development and function of the GABAergic system, including dlx5, 
have been involved in Rett syndrome, a developmental abnormality 
with autistic features (Horike et al., 2005); furthermore, alterations 
in the development of GABAergic neuron circuitry have been found 
in mice lacking the Methyl-CpG binding protein 2 (MeCP2) gene, 
whose mutations are responsible for Rett syndrome (Medrihan 
et al., 2008; Zhang et al., 2010). Lastly, a large number of synaptic-
related genes have been implicated in small subsets of patients with 
ASDs (in total, accounting for probably less than 3–4% of the cases) 
and Courchesne, 2005) but begin to show larger head measures at 
about 4 months of age (Gillberg and de Souza, 2002; Courchesne 
et al., 2005; Redcay and Courchesne, 2005). These findings suggest 
that autism may be underlain by either problems in early postnatal 
life and/or processes of embryonic development on which these 
postnatal events depend. Structural imaging of individuals with 
autism has shown that differences in brain volume, including both 
white and gray matter, diminish after the age of 5 years (Hazlett 
et al., 2005), although some studies have reported increases in gray 
matter volume in adolescents and adults with ASD (Lotspeich et al., 
2004; Palmen et al., 2005; Hazlett et al., 2006), particularly in PFC 
(Mitchell et al., 2009).
Although there is no clear mechanism accounting for the dys-
regulation in the trajectory of brain growth in ASD, one hypoth-
esis stipulates that it is the consequence of altered regulation of 
neural stem cell proliferation or differentiation arising before birth 
(Vaccarino et al., 2009). Further evidence that early embryonic devel-
opmental events are implicated in the pathophysiology of autism 
comes from post mortem studies demonstrating a fundamental 
change in cortical structure. Patients with autism were shown to 
have an increased packing density of mini-columns, which are verti-
cal (radial) assemblies of neurons thought to be anatomically and 
functionally interconnected (Casanova et al., 2003, 2006).
Several underlying mechanisms could explain macrocephaly 
and minicolumn pathology, all based on altered embryonic corti-
cal development (Figure 3). The first is an increase in the number 
of radial units in the embryonic cerebral cortex, which in turn is 
thought to depend upon an increase in the number of “founder” 
NSCs in the cortical primordium (Rakic, 1995) (Figure 3). This 
mechanism is supported by the occurrence of mutations in pten, a 
gene that regulates embryonic stem cell proliferation (Eng, 2003) 
in a small number of autistic patients with macrocephaly (Butler 
et al., 2005). Abnormal expression of this gene in NSCs would 
likely result in an intrinsic alteration of stem cells. Interestingly, 
an animal model of pten mutations shows increased brain size 
and social deficits (Kwon et al., 2006), although this mutation 
was in differentiated neurons, not intrinsically affecting NSCs. In 
Fragile X syndrome, which frequently presents with symptoms of 
autism, fetal NSCs have been shown to differentiate into neurons 
at greater rates (Castren et al., 2005) and to misexpress multiple 
genes involved in proliferation and differentiation (Bhattacharyya 
et al., 2008). Mutant embryonic NSCs isolated from mice lacking 
the fragile X mental retardation protein (FMRP) due to a deletion 
in the fmr1 gene differentiate in greater numbers into immature 
neurons (Castren et al., 2005). These findings are similar to those 
obtained in Drosophila germline stem cells lacking an ortholog of 
the fmr1 gene (Yang et al., 2009). Thus, the pten and fmr1 mouse 
models of ASD support the hypothesis that an intrinsic abnor-
mality in NSC is responsible for features of these disorders. Two 
members of the TF-II family of transcription factors involved in 
Williams syndrome, another disorder with abnormal social behav-
ior, have been shown in mice to regulate specific gene targets that 
may be involved in embryonic stem cell differentiation (Makeyev 
and Bayarsaihan, 2009).
GABA  interneurons  surround  each  minicolumn,  and  some 
genetic evidence and post mortem data suggest a GABAergic abnor-
mality in ASD (Fatemi et al., 2002). Multiple genes involved in the 
Figure 3 | Two neuronal cell types, excitatory (blue) and inhibitory (red), 
contribute to minicolumn structure and functional balance in cortex. 
Autism associated genes play roles in the processes underlying the 
generation and migration of these cortical neurons. The disruption of these 
genes may determine some cortical abnormalities in autism.www.frontiersin.org  September 2010  | Volume 4  | Article 59  |  7
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with schizophrenia are likely heterogenous, with pathology in some 
determined by a component of neuronal functioning that arises 
postnatally and in others, determined by earlier disruptions of pat-
terning and neurogenesis.
AFFEctivE DiSorDErS
Patients with major depression have been found to have smaller 
hippocampi (Videbech and Ravnkilde, 2004) and smaller ante-
rior cingulate cortical regions (Caetano et al., 2006). Connectivity 
and functioning of prefrontal and cingulate cortices have also 
been shown to be abnormal in individuals with major depression 
(Drevets, 2000; Grimm et al., 2008; Vasic et al., 2009). A recent 
longitudinal study of people at high familial risk for developing 
depression show thinning of the cerebral cortex, particularly in 
right-sided frontal and parietal areas (Peterson et al., 2009). This 
thinning was present even in children and adolescents prior to 
the onset of any mood episode, suggesting that structural changes 
that result from abnormal early cortical pruning during infancy or 
adolescence may be a predisposing factor in depression. In patients 
with bipolar disorder with psychotic symptoms, neuroanatomi-
cal and neuropsychological findings are similar to those found in 
patients with schizophrenia (Murray et al., 2004). In non-psychotic 
bipolar disorder, patients presenting at the first episode of illness 
have shown decreased volume in prefrontal and temporal cortex 
(Hirayasu et al., 1999; Strakowski et al., 1999; Kasai et al., 2003). 
Bipolar disease progression is associated with ventricular enlarge-
ment and stronger reductions of the PFC which correlate with 
impaired functioning during manic episodes (Bearden et al., 2001; 
Blumberg et al., 2003).
Post mortem studies have demonstrated that prefrontal cortical 
regions have abnormal densities of pyramidal, GABAergic and glial 
cells in patients with depression. Medium to large pyramidal neurons 
appear to be lower in density and smaller in soma size (Rajkowska 
et al., 1999, 2005; Law and Harrison, 2003) while smaller neurons 
and those in layers III, V may be increased in density (Chana et al., 
2003; Rajkowska, 2003). Glial cell density in patients with depres-
sion appears significantly reduced (Ongur et al., 1998; Rajkowska 
et al., 1999; Cotter et al., 2001, 2002; Uranova et al., 2004). These 
findings suggest that abnormal prenatal development of stem/pro-
genitor cells that generate the neurons populating different cortical 
layers and abnormal development of glial elements may account 
for structural brain abnormalities in depression.
Post mortem work has also examined the levels of signaling 
factors in patients with depression. In frontal cortical regions, 
FGF ligand and receptor levels as well as BDNF receptor levels 
were shown to be altered in patients with depression. Findings 
generally show reduced expression (Evans et al., 2004; Sibille et al., 
2004) but some point to upregulated receptor levels (Tochigi 
et al., 2008). Altered gene expression in the mature cortex may 
suggest a role for FGF and other important mediators of neu-
ronal growth in mood disorders in the adult brain. However, 
they may also reflect a genetic defect that may have contributed 
to an earlier altered developmental trajectory. Parallel findings 
in model animal systems (Chen et al., 2008) and patients with 
mood disorders (Rajkowska et al., 2001; Valentine and Sanacora, 
2009) suggest a role for FGF in both embryonic and mature brain 
functions (Figure 4).
(Buxbaum, 2009; Radyushkin et al., 2009). Thus, it appears that 
abnormalities in both the early-determined size and scaffolding of 
the cerebral cortex and later developing synaptic connections may 
play a role in individual cases of autism.
SchizophrEniA
In schizophrenia, retrospective studies have suggested that head 
circumference is decreased at birth and developmental delays are 
present in early childhood, both of which implicate prenatal and 
early postnatal alterations in forebrain development (Cannon et al., 
2002). The occurrence of prodromal symptoms in the majority of 
cases (Hafner et al., 1994), as well as the presence both prior to and 
after onset of illness of neuropsychological deficits (Crespo-Facorro 
et al., 2007) also implicates disruption of forebrain development. 
Neuropsychological dysfunction implicates the PFC in patients 
with schizophrenia, the cortical region that has expanded most 
extensively in mammalian evolution and that has been suggested 
to rely on key evolutionary developments in stem cell function 
(Martinez-Cerdeno et al., 2006).
Altered hippocampal development has also been implicated in 
the pathogenesis of schizophrenia (Kobayashi, 2009). Total brain 
gray matter and hippocampal volumes are reduced at the time of 
first episode in schizophrenia (Ohnuma et al., 1997; Gur et al., 1999) 
and at times later in the disease course, volume reductions have 
been observed in PFC, hippocampus and temporal lobe (Shenton 
et al., 2001). Longitudinal studies with structural imaging show that 
both the PFC and the medial temporal lobe become progressively 
smaller during the period when psychosis develops and that dorsal 
prefrontal regions experience even more loss as illness progresses, 
consistent with a neurodegenerative process (Pantelis et al., 2007). 
Post mortem studies of the cerebral cortex of patients with schizo-
phrenia have shown reductions in neuropil (Selemon et al., 1998), 
as well as in GABAergic cells expressing PV and reelin (Guidotti 
et al., 2000; Fatemi et al., 2001; Hashimoto et al., 2008). Post mortem 
analysis of the hippocampus also shows evidence for an abnormal 
GABAergic system and suggests that important signaling pathways 
are altered, including WNT and TGFbeta (Benes et al., 1998, 2007; 
Todtenkopf and Benes, 1998; Arnold et al., 2005). While these post 
mortem findings may reflect changes in the adult brain due to 
disease progression and medication effects, alterations in cortical 
neurodevelopmental processes could also create vulnerabilities that 
develop later in life.
Genes that are implicated in stem cell regulation, including neu-
regulin, disc-1, wnt related genes, bdnf and fgfr1, have been associ-
ated with schizophrenia in genetic association and post mortem 
studies, suggesting NSCs dysregulation in at least some cases. Mouse 
models lacking fgfr1 embryonically have smaller hippocampi and 
cortical interneuron deficits similar to those in patients with psy-
chosis (Ohkubo et al., 2004). Similarly, deficient bdnf, neuregulin 
and disc-1 genes in mice mimic various aspects of the disorder 
(Ayhan et al., 2009; Brandon et al., 2009; Meyer and Morris, 2009). 
Conversely, mutations found in some patients with schizophrenia 
have significant effects on cortical stem cell development. Mice 
lacking the genes within the 22q11 mutation (velocardiofacial 
syndrome, a known chromosomal abnormality predisposing to 
schizophrenia) have abnormal neurogenesis, specifically affecting 
upper cortical layers (Meechan et al., 2009). As in autism, patients Frontiers in Neuroscience  |  Neurogenesis    September 2010  | Volume 4  | Article 59  |  8
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granule cells or olfactory interneurons (Ma et al., 2009a). A large 
proportion of postnatally generated neurons die and only some 
are incorporated into the existing circuitry. It has been proposed 
that this pace may be adaptive in order to enhance the sensitivity of 
the system while the new neurons fully integrate. Environmental 
and activity-dependant factors may be critical for regulating how 
these cells pass appropriately through these stages and hence how 
newly born neurons will participate in normal brain functioning 
and potentially compensate for pathological states.
Like embryonic NSCs and radial glial cells, adult astroglial NSCs 
and progenitor cells in the SVZ and SGZ express several RTKs 
including fgfr1, fgfr2 and fgfr3, bmpr-1a/alk3 as well as egfr, and have 
active SHH and Notch signaling systems. Adult NSC maintenance 
and self-renewal depends on secreted FGF, BMP, SHH, and EGF, 
acting in conjunction with the cell-attached Notch signaling sys-
tem (Machold et al., 2003; Zheng et al., 2004; Lie et al., 2005; Mira 
et al., 2010). For example, the number of proliferating cells in the 
adult SVZ is reduced by 40% in fgf2 KO mice (Zheng et al., 2004). 
FGF2 increases cell cycle re-entry and BMP promotes quiescence 
in adult NSCs, and thus, as in the embryo, the balance of these 2 
extrinsic factors is likely to be important for proper regulation of 
adult NSC proliferation and differentiation (Ming and Song, 2005; 
Mira et al., 2010).
Much evidence has been found linking major neuropsychiatric 
disorders to altered regulation of adult NSCs and to the molecular 
systems involved in their maintenance and differentiation. The 
SGZ of the DG has been the region of the most research focus. 
DG functioning underlies mood, memory, and reward, which are 
impaired in schizophrenia, major depression and bipolar disor-
der. In animal models of depression, schizophrenia, and bipolar 
disorder, the activity of SGZ stem cells is reduced. For example, 
ADult nEurAl StEm cEllS
Neural Stem Cells in the adult brain are present in regions around 
the ventricles, specifically in the SVZ, which gives rise to neurons 
that migrate to the olfactory bulb via the rostral migratory stream. 
A region in the hippocampal dentate gyrus (DG), the subgranular 
zone (SGZ), also contains NSCs which generate DG granule cells. 
Interestingly, over 80% of the interneurons in the olfactory bulb 
and 10% of granule cells in the DG are replaced by this mecha-
nism in the period of about 1 year, suggesting that a portion of 
these neurons are under constant turnover (Lemasson et al., 2005; 
Ninkovic et al., 2007; Imayoshi et al., 2008).
The contribution of adult stem cells to regeneration and neu-
roplasticity in adult patients with mental illness has received 
relatively  more  attention  than  the  role  of  embryonic  NSCs 
in these disorders. Interestingly, as more is understood about 
the intrinsic and extrinsic regulation of both embryonic and 
adult NSCs, common mechanisms are being identified which 
may underlie disruption in both types of NSCs in disease states 
(Bordey, 2006).
While the identity of NSCs in the adult brain is not clearly docu-
mented, it appears likely that they have many features characteris-
tic of astroglia (Imura et al., 2003; Alvarez-Buylla and Lim, 2004; 
Liu et al., 2006). Like embryonic radial glia, adult SVZ NSCs have 
GABAA receptors which limit their proliferation in response to 
GABA released by neuroblasts, suggesting negative feed-back regu-
lation via non-synaptic GABAergic signaling between neuroblasts 
and GFAP-expressing NSCs (Liu et al., 2005).
Neuronal stem cells in the adult brain pass through several 
stages from quiescent multipotent cell (astroglial in nature, slowly 
dividing) to amplifying neural progenitors which rapidly prolif-
erate and generate immature neurons, which finally mature into 
Figure 4 | evidence from model animal systems on fibroblast growth factor, cortical anatomy and functioning (top of each frame) converges with results 
from clinical studies, cortical anatomy and functioning (bottom of each frame) demonstrating how FgF may have a critical role in affective disorder 
psychopathology. FGF signaling contributes to normal cortical thickness and youth at risk for depression show early deficits in cortical thickness (A). The density of 
neurons in prefrontal cortex is reduced in both mice lacking FGF receptors and patients with bipolar disorder (B). A new target for antidepressant treatment is glial 
functioning in which FGF signaling plays a significant role (C). FGF receptor 1 plays a role in dentate gyrus adult neurogenesis in mice and, in patients with 
depression, antidepressant treatment has been correlated with increased dentate gyrus proliferation (D).www.frontiersin.org  September 2010  | Volume 4  | Article 59  |  9
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(Ma et al., 2009b). In summary, neuropsychiatric disorders may 
have links to stem cell biology in the mature as well as the devel-
oping brain.
thE FuturE oF StEm cEllS AnD intErvEntionS: 
intEgrAting humAn AnD AnimAl knowlEDgE
Work in animal models reveals fundamental processes of brain 
development that are important to generate and test hypotheses 
concerning the pathogenesis of human mental disorders. This 
opens the possibility of manipulating stem cells in clinical popu-
lations. Avenues of research are utilizing general knowledge about 
stem cells to (1) use manipulated stem cells in a rehabilitative capac-
ity in patients and (2) use stem cells from patients to understand 
pathophysiology and test candidate drugs for reversing abnormal 
cellular functions. We will review briefly here how knowledge about 
stem cell biology from both humans and animal models is being 
applied to develop these new research directions.
Research on the use of stem cells for rehabilitation was originally 
motivated by the potential for direct development of new neurons 
from stem cells that might replace lost neurons that are at the center 
of pathophysiology. For example, in degenerative illnesses such as 
Parkinson’s disease and Amyotrophic Lateral Sclerosis, specific pop-
ulations of neurons, dopaminergic cells and spinal motor neurons 
respectively, are progressively lost. Stem cell research has sought 
to use either embryonic or other types of stem cells to generate 
replacement neurons that could be transplanted and incorporated 
into the CNS of patients (for a Review, see Hynes and Rosenthal, 
2000). This work has required knowledge acquired from animal 
models of the transcription and signaling factors that determine 
dopaminergic and spinal motor neuron fate and maturation. As 
researchers have pursued this goal, it has been shown that stem 
cells in animal model transplant recipients may have an indirect 
trophic role, i.e., reducing cell death, increasing metabolic functions 
and protecting remaining neurons from insults (Jung et al., 2004; 
Rafuse et al., 2005; Yasuhara et al., 2006). These findings may hold 
promise for future application of stem cell-derived therapies to 
neuropsychiatric disorders. Disorders such as schizophrenia and 
depression may have a neurodegenerative component, similar to 
neurological disorders for which the supportive role of stem cells 
has been demonstrated. The regions of the brain involved may be 
different for major affective and psychotic disorders than degen-
erative motor diseases – e.g., cortex and hippocampus – but these 
regions may be even better candidates for the application of stem 
cell support therapy given their nearby neurogenic zones. Extrinsic 
factors that influence the stem cell niches, like FGF and BMPs, will 
likely have an important role to play in these potential therapies.
Induced pluripotent stem cells (iPSCs) also hold great prom-
ise in their application to neuropsychiatric disorders. These 
pluripotent stem cells can be derived from skin fibroblasts or 
blood lymphocytes by introducing a combination of genes that 
confer stem cell like properties, essentially reprogramming the 
differentiated cells to behave like embryonically derived stem 
cells (Takahashi et al., 2007; Yu et al., 2007; Muller et al., 2008). 
Takahashi and colleagues reported the first generation of human 
iPSCs in 2007. They achieved this by introducing the oct3/4, sox2, 
klf4, and c-myc genes into fibroblasts with retroviral vectors. 
As iPSCs reproduce the essential features of human embryonic 
chronic stress leads to a depression-like phenotype in rodents, 
suppresses neurogenesis in the SGZ and reduces FGF2 expression 
in hippocampus (Warner-Schmidt and Duman, 2006). Findings 
from post mortem studies have demonstrated that numbers of 
proliferating cells in the DG are decreased in psychotic disorders 
(Reif et al., 2006); furthermore, abnormal FGF expression has 
been documented in the post mortem hippocampus of depressed 
and schizophrenic patients (Gaughran et al., 2006). In this study, 
neither antidepressant treatment nor the presence of affective 
disorders were found to be correlated with altered numbers of 
hippocampal dividing cells. However, other post mortem work 
has demonstrated that patients who received antidepressant treat-
ment did show a greater number of neural progenitor and dividing 
cells in the DG than untreated patients with depression (Boldrini 
et al., 2009). Furthermore, antidepressant treatment increases hip-
pocampal neurogenesis in both rodents (Malberg et al., 2000) and 
non-human primates (Perera et al., 2007). Chronic antidepres-
sant administration to rodents has been shown to increase FGF2 
expression in astrocytes and neurons within and outside of the 
hippocampus, suggesting that FGF signaling may be involved in 
the neurogenic action of antidepressants. In support of this idea, 
the infusion of FGF2 into the ventricles of adult rats increases 
cell proliferation and reduces depression-like behavior in rodents 
(Turner et al., 2008). Also, conditional knockout of fgfr1 in neu-
ronal stem cells by nestin-Cre results in reduced proliferation 
and neurogenesis in the adult DG (Zhao et al., 2007). New data 
suggest FGF2 may be specifically involved in the modulation of 
anxiety/fear behavior in rodents (Perez et al., 2009). However, it 
is currently controversial whether ongoing hippocampal neu-
rogenesis is required for the therapeutic action of antidepres-
sants. Some have proposed that hippocampal neurogenesis may 
be limited to mediating the beneficial action of antidepressants 
on cognition. One problem is the limitations of animal models 
of depression in which behavior may rely on mechanisms that 
are peripheral to human disease (Santarelli et al., 2003; Sahay 
and Hen, 2007; Holick et al., 2008; David et al., 2009). Hence, the 
specific role of FGF2 on the development and function of systems 
that subserve affective and cognitive functions in humans is still 
somewhat unclear.
Gene products implicated with neuropsychiatric illnesses via 
association studies have been shown to affect hippocampal neu-
rogenesis, most likely by working intrinsically within stem and 
progenitors cells. The gene with the strongest association to schiz-
ophrenia, disc-1, has been shown to regulate the maturation of 
newborn neurons in the mature brain. When expression of disc-1 
is suppressed, neurons mature too quickly (Kim et al., 2009). This 
may involve a disruption of the balance between those signaling 
pathways that maintain neuronal stem cells, such as FGF, and those 
that advance their differentiation into neurons, such as BMP2/4. A 
role in progenitor cell maintenance and neuronal   differentiation 
within hippocampal NSCs has been also identified for systems that 
regulate gene expression by methylating or acetylating specific his-
tone proteins in stem and progenitor cells (Wu and Sun, 2009; 
Yu et al., 2009). A gene that has been associated with some forms 
of autism, gadd45b, may also play a role in these pathways as it 
increases progenitors in the DG after electroconvulsive treatment, 
perhaps by controlling fgf gene expression by DNA methylation Frontiers in Neuroscience  |  Neurogenesis    September 2010  | Volume 4  | Article 59  |  10
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investigating the role of individual genes in brain development 
was to create a transgenic mouse model with either gene inactiva-
tion, gene overexpression, or mutations that mimic the mutations 
found in human disease. This remains a powerful approach, and 
indeed, animal work has provided useful experimental frame-
works in which the functional impact of specific gene mutations 
can be tested. However, there are important differences in the 
development of the rodent brain and the human brain, which 
are reflected in the diversity of gene splice variants expressed 
during animal and human brain development (Johnson et al., 
2009b). While work in animals continues to represent an essential 
reference point against which differences in gene expression and 
function found in humans can be compared, the use of iPSCs 
will allow us to test hypotheses about the effects of specific gene 
variants and mutations in developing human cells. Using iPSC 
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gene mutations/variants present an individual patient, lead to 
abnormal cell proliferation or neuronal differentiation in human 
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which to test candidate pharmacological agents for their ability 
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The study of NSCs in multiple model systems will continue to 
inform our understanding of normal brain structure and function. 
The application of this information to patient populations is slowly 
shedding light on the pathophysiology of major neuropsychiatric 
diseases. The advent of new techniques for manipulating human 
cells may accelerate this process of discovery and may hold real 
promise for improving the lives of patients with mental illness.
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